CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $153.83M, above the global median of $18.73M
- FinancialsAltman Z-Score 0.78: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.18BCNY773.63M · vs all stocks (USD)
Revenue (TTM)
379.28MCNY56.64M · vs all stocks (USD)
Profit Margin
-2.76%Beta
0.2000xvs all stocks
52-Week Change
-50.14%vs all stocks
Market Capitalization
5.18BCNY773.63M · vs all stocks (USD)
Enterprise Value
8.33BCNY1.24B · vs all stocks (USD)
Forward P/E
4.96xPrice to Sales (TTM)
13.66xPrice to Book (MRQ)
0.8600xEnterprise to Revenue
21.96xEnterprise to EBITDA
-6.93xGross Margin
13.90%Profit Margin
-2.76%Operating Margin
-54.21%Return on Assets (TTM)
-7.57%Return on Equity (TTM)
-22.65%Revenue (TTM)
379.28MCNY56.64M · vs all stocks (USD)
Revenue per Share (TTM)
0.4040CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-53.50%Gross Profit (TTM)
-663.69MCNY-99.11M · vs all stocks (USD)
EBITDA (TTM)
-1.20BCNY-179.38M · vs all stocks (USD)
Net Income (TTM)
-1.56BCNY-232.84M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-75.73%Operating Cash Flow (TTM)
487.29MCNY72.77M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.03BCNY153.83M · vs all stocks (USD)
5-Year Average Dividend Yield
1.40%vs all stocks
Payout Ratio
85.51%Minority Interest (Equity)
-1.74MCNYFY2025 · Dec 31, 2025Revenue
798.06MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
820.12MCNYFY2025 · Dec 31, 2025Gross Profit
-22.06MCNYFY2025 · Dec 31, 2025Operating Income
-417.86MCNY-62.40M · vs all stocks (USD)
Pre-tax Income
-1.63BCNYFY2025 · Dec 31, 2025Income Tax Expense
-257.47MCNYFY2025 · Dec 31, 2025Net Income
-1.37BCNYFY2025 · Dec 31, 2025EBIT
-1.49BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-257.53MCNYFY2025 · Dec 31, 2025Research & Development
46.35MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
185.25MCNYFY2025 · Dec 31, 2025Other Operating Expenses
38.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
37.01MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
139.00MCNYFY2025 · Dec 31, 2025EPS (Basic)
-1.45CNYFY2025 · Dec 31, 2025EPS (Diluted)
-1.45CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
939.84MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
939.84MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-1.37BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.40MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-2.65BCNYFY2025 · Dec 31, 2025Free Cash Flow
-2.72BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
76.90MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-1.37BCNYFY2025 · Dec 31, 2025Other Non-cash Items
156.55MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-947.80MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-488.25MCNYFY2025 · Dec 31, 2025Capital Expenditures
-66.14MCNYFY2025 · Dec 31, 2025Purchase of Investments
-530.87MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-597.01MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.42BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.83BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-276.56MCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.21MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-698.51MCNYFY2025 · Dec 31, 2025Shares Outstanding
940.86MSharesUpdated Sep 22, 2026Float Shares
388.16MSharesUpdated Sep 22, 2026% Held by Insiders
62.12%vs all stocks
% Held by Institutions
4.03%vs all stocks
Total Cash (MRQ)
69.12MCNY10.32M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0740CNYUpdated Sep 22, 2026Total Debt (MRQ)
3.14BCNY469.50M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5197xCurrent Ratio (MRQ)
1.31xBook Value per Share (MRQ)
6.41CNYUpdated Sep 22, 2026Total Assets
10.63BCNY1.59B · vs all stocks (USD)
Total Current Assets
5.15BCNYFY2025 · Dec 31, 2025Total Liabilities
4.36BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.49BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
269.57MCNYFY2025 · Dec 31, 2025Total Current Liabilities
4.09BCNYFY2025 · Dec 31, 2025Cash
76.90MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.02MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
78.91MCNYFY2025 · Dec 31, 2025Other Short-term Investments
438.51KCNYFY2025 · Dec 31, 2025Accounts Receivable
2.55BCNYFY2025 · Dec 31, 2025Inventory
1.32BCNYFY2025 · Dec 31, 2025Accounts Payable
341.10MCNYFY2025 · Dec 31, 2025Short-term Debt
3.07BCNYFY2025 · Dec 31, 2025Other Current Liabilities
30.27MCNYFY2025 · Dec 31, 2025Long-term Debt
53.20MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
58.11MCNYFY2025 · Dec 31, 2025Common Stock (Book)
941.00MCNYFY2025 · Dec 31, 2025Retained Earnings
2.55BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.28BCNY937.67M · vs all stocks (USD)
Treasury Stock
13.89MCNYFY2025 · Dec 31, 202552-Week Low
4.21CNYUpdated Sep 22, 202652-Week High
12.30CNYUpdated Sep 22, 202652-Week Change
-50.14%vs all stocks
Beta
0.2000xvs all stocks
50-Day MA
5.94CNYUpdated Sep 22, 2026200-Day MA
7.08CNYUpdated Sep 22, 2026Avg 10-Day Volume
18.48MSharesUpdated Sep 22, 2026Avg 30-Day Volume
38.08MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-1.74CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.78: distress zoneCritical
Altman Z-Score: 0.78
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $153.83M, above the global median of $18.73MNotable
Levered free cash flow (USD): 153,834,347.113Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Tong Ren Tang Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Vireo Growth Inc.
Tier 1ProductionApproval-Gated PipelineFlowInterface
Achieve Life Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Boji Medical & Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tibet Duorui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Teyi Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pharming Group N.V.
Tier 1ProductionApproval-Gated PipelineRule
Gyre Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Solid Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Olema Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Md Entertainment Tbk
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Beijing Xiaocheng Technology Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated